Application
Immunohistochemistry of NAT11 in mouse thymus tissue with NAT11 antibody at 5 ug/ml.Application
Western blot analysis of NAT11 in human thymus tissue lysate with NAT11 antibody at (A) 1 and (B) 2 ug/ml.Application
Immunofluorescence of NAT11 in mouse thymus tissue with NAT11 antibody at 20 μg/mL.| Product Name | NAT11 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to NAT11N-terminal acetylation is one of the most common protein modifications in eukaryotes, occurring on approximately 57% and 84% on yeast and human proteins respectively. There are several N-terminal acetylating enzyme complexes (NatA – NatE). Unlike the other complexes, NatD is composed of a single protein, NAT11, and has recently been described to acetylate the Serine N-termini of histones H2A and H4 in yeast. The role these modifications play is unknown; yeast that do not express NAT11 grow at normal rates and have no observable phenotypes. The role of the human homolog is likewise unknown. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ELISAICC/IFIHC-PWB |
| ICC/IF:1:200~1:500 IHC-P:1:50~1:200 WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | Nacetyltransferase11 N-acetyltransferase 11 N(alpha)-acetyl transferase 40 NAA40 N(alpha)acetyl transferase 40 Nacetyltransferase 11 NAT11 N(alpha)acetyl transferase40 N acetyltransferase 11 N(alpha) acetyl transferase 40 |
|---|---|
| Target | NAT11 |
| Tissue Specificity | This antibody is specific for NAT11 |
Application
Immunohistochemistry of NAT11 in mouse thymus tissue with NAT11 antibody at 5 ug/ml.
Application
Western blot analysis of NAT11 in human thymus tissue lysate with NAT11 antibody at (A) 1 and (B) 2 ug/ml.
Application
Immunofluorescence of NAT11 in mouse thymus tissue with NAT11 antibody at 20 μg/mL.| Positive Control | Blocking Peptide: |
|---|---|
| Application Notes | ICC/IF:1:200~1:500 IHC-P:1:50~1:200 WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | PBS containing 0.02% sodium azide |
